Predictors of multidisciplinary tumor board implementation in head and neck cancer: Global insights
摘要
To identify institutional and organizational determinants associated with the adoption of multidisciplinary tumor boards (MDTBs) in head and neck cancer management across diverse healthcare settings.
MethodsThis cross-sectional analysis used data from 566 responses, corresponding to 457 unique centers across 101 countries participating in the IFOS–YO-IFOS global survey. Centers were categorized by income level, region, and case volume. Logistic regression identified predictors of systematic MDTB use.
ResultsAmong responding centers, MDTBs were systematic in 89.1% of North America, 88.9% of European and 87.5% of Oceanian centers, compared with 37.5% in Africa and 32.6% in MENA. High annual case volume (> 200 cases/year) (OR = 3.4, p < 0.001), university affiliation (OR = 2.7, p = 0.002), and access to intensity-modulated radiotherapy (OR = 2.1, p = 0.01) independently predicted full MDTB integration. Centers citing economic barriers showed a 65% reduction in odds of MDTB implementation.
ConclusionsOur findings suggest that multidisciplinary management in head and neck oncology is strongly influenced by institutional resources and organizational models rather than geography alone. Strengthening MDTB frameworks in low- and middle-income regions could substantially narrow global care inequities.